Clinical Trials in Pittsburgh

Showing 18401-18420 of 21,047 trials

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

NCT00258856

The study is designed to evaluate the persistence of bactericidal antibodies in subjects aged 7 to 15 years (not yet 16 years) who had been vaccinated five years previously in Study 603-02. In addition, the kinetics of the antibody response will be evaluated in a subset of participants who will receive a booster dose of Menactra® vaccine and children in the same age group not previously vaccinated with a meningococcal vaccine or had meningitis disease who will receive a dose of Menactra® vaccine.

MeningitisMeningococcal Infection

Sanofi Pasteur, a Sanofi Company234 participantsStarted Jan 2006

Jonesboro, Arkansas, United States • Little Rock, Arkansas, United States • Marietta, Georgia, United States +8 more locations

COMPLETEDPhase 2< 1 mile

A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease

NCT01476696

The purpose of this study is to determine the correct prasugrel dosage to be given to children with sickle cell disease (SCD).

Sickle Cell Disease

Eli Lilly and Company33 participantsStarted Nov 2011

Oakland, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +6 more locations

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease

Find Trials by Condition in Pittsburgh

Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)

A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Uncertainty Management Intervention

Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer

Alglucosidase Alfa Temporary Access Program

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.

Surgical Intervention in Bariatric Patients: Excess Weight Loss in the Morbidly Obese Following Gastric Plication

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients

A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321

Open, Prosp, Rand. Invest. Evaluating Pain With Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase

A Study of Clinical Outcomes of the REALIZE Adjustable Gastric Band-C

Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma

A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus